NO20083869L - Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte - Google Patents

Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte

Info

Publication number: NO20083869L
Authority: NO; Norway
Prior art keywords: pain; beta; treatment; alkyl; inflammatory disorders
Prior art date: 2006-03-09

Application number

NO20083869A

Other languages

English (en)

Norwegian (no)

Inventor

Andrew Douglas Baxter

Original Assignee

Sosei R & D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-09

Filing date

2008-09-09

Publication date

2008-10-07

2008-09-09 Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd

2008-10-07 Publication of NO20083869L publication Critical patent/NO20083869L/no

Links

206010065390 Inflammatory pain Diseases 0.000 title 1
208000027866 inflammatory disease Diseases 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
-1 CF 3 Chemical group 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
230000006052 T cell proliferation Effects 0.000 abstract 1
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000000770 proinflammatory effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

NO20083869A 2006-03-09 2008-09-09 Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte NO20083869L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0604826.8A GB0604826D0 (en)	2006-03-09	2006-03-09	The treatment of inflammatory disorders and pain
PCT/GB2007/000821 WO2007102011A1 (en)	2006-03-09	2007-03-09	The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain

Publications (1)

Publication Number	Publication Date
NO20083869L true NO20083869L (no)	2008-10-07

Family

ID=36241342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20083869A NO20083869L (no)	2006-03-09	2008-09-09	Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte

Country Status (12)

Country	Link
US (1)	US20100016357A1 (pt)
EP (1)	EP1993544A1 (pt)
KR (1)	KR20090021141A (pt)
CN (1)	CN101426501A (pt)
AU (1)	AU2007222209A1 (pt)
BR (1)	BRPI0708624A2 (pt)
CA (1)	CA2646883A1 (pt)
GB (1)	GB0604826D0 (pt)
IL (1)	IL193943A0 (pt)
MX (1)	MX2008011508A (pt)
NO (1)	NO20083869L (pt)
WO (1)	WO2007102011A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201714745D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714736D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714740D0 (en) *	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en) *	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE756973A (fr) *	1969-10-08	1971-04-02	Smith Kline French Lab	Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant
US3985887A (en) *	1973-10-19	1976-10-12	Smithkline Corporation	3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as β-adrenergic stimulants
KR20050007460A (ko) *	2002-04-19	2005-01-18	아스션 디벨롭먼트 에이/에스	베타-2 아드레날린 수용체 아고니스트 및 아미노당의배합물 및 면역조정 장애의 치료에 있어서의 이들의 용도
EP1613266A4 (en) *	2003-04-15	2009-05-06	Theraquest Biosciences Llc	METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
WO2005102296A2 (en) *	2004-04-23	2005-11-03	Heptagen Limited	Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
WO2006027579A2 (en) *	2004-09-07	2006-03-16	Sosei R & D Ltd.	The treatment of inflammatory disorders and pain
US8426475B2 (en) *	2005-04-13	2013-04-23	Astion Development A/S	Treatment of connective tissue diseases of the skin

2006
- 2006-03-09 GB GBGB0604826.8A patent/GB0604826D0/en not_active Ceased
2007
- 2007-03-09 EP EP07705329A patent/EP1993544A1/en not_active Withdrawn
- 2007-03-09 AU AU2007222209A patent/AU2007222209A1/en not_active Abandoned
- 2007-03-09 BR BRPI0708624-5A patent/BRPI0708624A2/pt not_active IP Right Cessation
- 2007-03-09 KR KR1020087023354A patent/KR20090021141A/ko not_active Withdrawn
- 2007-03-09 WO PCT/GB2007/000821 patent/WO2007102011A1/en not_active Ceased
- 2007-03-09 US US12/282,265 patent/US20100016357A1/en not_active Abandoned
- 2007-03-09 MX MX2008011508A patent/MX2008011508A/es not_active Application Discontinuation
- 2007-03-09 CA CA002646883A patent/CA2646883A1/en not_active Abandoned
- 2007-03-09 CN CNA2007800083869A patent/CN101426501A/zh active Pending
2008
- 2008-09-07 IL IL193943A patent/IL193943A0/en unknown
- 2008-09-09 NO NO20083869A patent/NO20083869L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2007102011A1 (en)	2007-09-13
CA2646883A1 (en)	2007-09-13
BRPI0708624A2 (pt)	2011-06-07
MX2008011508A (es)	2008-10-23
IL193943A0 (en)	2009-08-03
US20100016357A1 (en)	2010-01-21
KR20090021141A (ko)	2009-02-27
AU2007222209A1 (en)	2007-09-13
CN101426501A (zh)	2009-05-06
EP1993544A1 (en)	2008-11-26
GB0604826D0 (en)	2006-04-19

Legal Events

Date	Code	Title	Description
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20071534L (no)	2007-03-27	Behandling av inflammatoriske forstyrrelser og smerte
NO20076658L (no)	2008-04-04	Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes
NO20083869L (no)	2008-10-07	Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte
ATE517896T1 (de)	2011-08-15	P38-kinase-inhibitoren
NZ593030A (en)	2013-11-29	Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
NO20010991D0 (no)	2001-02-27	Pyrro-indoler, pyrido-indoler og azepino-indoler som 5-HT2C- agonister
NO20075623L (no)	2008-01-17	Benzodioksan- og benzodioksolanderivater og deres anvendelse
NO20075626L (no)	2007-12-18	Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
TW200626601A (en)	2006-08-01	Novel compounds
EA201000562A1 (ru)	2010-10-29	Производные n-(пиразол-3-ил)бензамида в качестве активаторов глюкокиназы
UY30323A1 (es)	2007-10-31	Uso de bifenilamidas de acido arilcarboxilico para el tratamiento de semillas
JP2016520515A5 (pt)	2017-04-13
MX2009004441A (es)	2009-05-22	Derivados de indazol utiles como inhibidores de las isoformas de higado.
AR070701A1 (es)	2010-04-28	Derivados de fluoroglicosidos aromaticos, medicamentos que comprenden estos compuestos y uso de los mismos para producir un medicamento
EA201001367A1 (ru)	2011-04-29	Производные карбоксамид-гетероарила для лечения диабета
NO20071574L (no)	2007-03-26	Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander.
GT200600105A (es)	2007-02-14	Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.
SE0203304D0 (sv)	2002-11-07	Novel Coumpounds
CL2011003138A1 (es)	2012-06-22	N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion.
GB0402138D0 (en)	2004-03-03	Novel compounds
BRPI0409374A (pt)	2006-04-25	composto, composição farmacêutica, uso de pelo menos um composto, e, método para o tratamento de um distúrbio médico
LV11817A (lv)	1997-08-20	Arilalkil-amini un -amidi ar pretkrampju un neiroprotektivam ipasibam
MX2010007968A (es)	2010-08-04	Derivados de sulfonamida piperidina.
SE0202461D0 (sv)	2002-08-14	Novel compounds
MX2008001778A (es)	2008-04-07	Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.